Judge Expedites Pershing Square Lawsuit Against Allergan

Aug 28 2014 | 11:02am ET

Allergan Inc. may have to wait in line to proceed with its insider-trading lawsuit against Pershing Square Capital Management, but the hedge fund’s claims against the Botox-maker are getting the fast-track treatment denied Allergan.

Delaware’s chancellor, Andre Bouchard, granted Pershing Square and Valeant Pharmaceuticals International’s request for an expedited hearing of their case against Allergan. The two, which are working together on Valeant’s $53 billion hostile takeover bid for Allergan, want the courts to certify their request for a special meeting—at which they hope to take control of Allergan’s board—and to bar Allergan from making any acquisitions before that meeting.

Allergan this week announced that the meeting would be held on Dec. 18—pending a review of the 1,500 pages in consent forms from investors representing 31% of its shares submitted on Friday by Pershing Square and Valeant. But that meeting could be moved up following a three-day trial set to begin on Oct. 6.

Bouchard noted that “Allergan may not want a special meeting at all.”

Allergan has sued Pershing Square and Valeant in California federal court, accusing the two of insider trading and asking that Pershing Square’s 9.7% stake in the company be cancelled. But a judge in Santa Ana rejected Allergan’s bid for an expedited hearing, directing the parties to duke it out in Delaware.


In Depth

Part II: Roubini Talks Risk, Recovery And The Threat Of A Triple Dip Recession

Oct 21 2014 | 12:41pm ET

In the second half of our interview with Nouriel Roubini, FINalternatives editor...

Lifestyle

Balyasny Pays Over $6M For Lakefront House

Oct 22 2014 | 10:29am ET

A venture headed by hedge fund manager Dmitry Balyasny just paid $6.2 million for...

Guest Contributor

Hedge Funds Weather A Data Management Perfect Storm

Oct 22 2014 | 12:28pm ET

From a regulatory standpoint, nearly every development since the crisis has placed...

 

Videos

Editor's Note

    Guidelines for Guest Articles

    Oct 22 2014 | 9:46am ET

    We are always looking for guest articles from hedge fund managers and buy-side firms.

    If you are interested in submitting a contributed piece for possible publication on FINalternatives, please take a look at the specs. Read more…

 

Futures Magazine

October 2014 Cover

Deeply flawed risk benchmark

Most traders agree that proper risk management is the key to successful trading. However, many traders depend on the deeply flawed measure of standard deviation as a benchmark of risk. Here we put it ...

The Alpha Pages

TAP July/August 2014 Cover

The Alpha Pages Interview: Senator Rand Paul

Senator Paul sat down in the debut series of the Alpha Pages Interview to discuss the broken tax code, regulation surrounding Bitcoin, and his plans for the 2016 Presidential election.